Differential gene expression (DEG) analysis across all subsets identified unique transcriptional profiles for each CD34+ HSPC subset, with specific differences based on mobilization regimen (motixafortide versus plerixafor) and donor type (allo-donor versus patient with MM). The gene discussed is CD34; the disease is Miyoshi myopathy.